Liraglutide — Daily Ramp
Daily ramp: 0.6 → 1.2 → 1.8 → 2.4 → 3.0 mg over 5 weeks
Dose ladder
- Phase 1 / 5Ramp 1Week 10.6 mg
- Phase 2 / 5Ramp 2Week 21.2 mg
- Phase 3 / 5Ramp 3Week 31.8 mg
- Phase 4 / 5Ramp 4Week 42.4 mg
- Phase 5 / 5MaintenanceWeek 5+3 mg
What you'll need
Reference defaults for Liraglutide — Daily Ramp. Your provider may set different values — adjust as needed.
- Vial18 mgstarting size
- BAC water3 mlfor reconstitution
- Concentration6.00 mg/mlcomputed
- Duration5+ weeks5 phases
How the app runs this for you
Auto-advance phases
Liraglutide — Daily Ramp ramps automatically week by week — no manual tracking. The current phase and remaining weeks are visible on the home tab and the lock-screen widget.
Smart reminders
Per-protocol notifications fire at your chosen time. Missed-dose detection flags any log >15 minutes late, with one-tap resolve from the lock screen.
Body-map rotation
Each log records the injection site. The body map remembers recency so you don't reuse the same spot — especially important on multi-week protocols.
Side effects to watch for
Common in the GLP-1 category. The iOS app lets you track all of these on a timeline and surfaces patterns as your body adapts.
- Nausea, vomiting, diarrhea, constipation — most pronounced in the first weeks of titration
- Reduced appetite (the intended effect, but watch for muscle loss without protein intake)
- Fatigue, headache, dizziness early in titration
- Rare but serious: pancreatitis, gallbladder issues, severe dehydration
Defaults
- Vial size
- 18 mg
- BAC water
- 3 ml
- Concentration
- 6.00 mg/ml
- Total weeks
- 5+
Uses Liraglutide. Typical dose range: 0.6–3 mg. Public clinical dosing guidance. Not medical advice.
How Liraglutide — Daily Ramp compares to other GLP-1 protocols
5 protocols comparedQuick read of the dose ladders, durations, and concentrations across the glp-1 category.
| Protocol | Peptide | Duration | Phases | Concentration |
|---|---|---|---|---|
| Liraglutide — Daily Ramp | liraglutide | 5+ weeks | 5 | 6.00 mg/ml 18 mg / 3 ml |
| Semaglutide — Standard TitrationPopular | semaglutide | 16+ weeks | 5 | 5.00 mg/ml 10 mg / 2 ml |
| Semaglutide — Gentle Start | semaglutide | 16+ weeks | 3 | 5.00 mg/ml 10 mg / 2 ml |
| Tirzepatide — Standard TitrationPopular | tirzepatide | 20+ weeks | 6 | 15.00 mg/ml 30 mg / 2 ml |
| Tirzepatide — Aggressive | tirzepatide | 12+ weeks | 6 | 15.00 mg/ml 30 mg / 2 ml |
Liraglutide — Daily Ramp FAQ
Answers, not hype.
Liraglutide — Daily Ramp is a 5-week GLP-1 protocol using Liraglutide. Daily ramp: 0.6 → 1.2 → 1.8 → 2.4 → 3.0 mg over 5 weeks
The standard cycle is 5+ weeks across 5 dose phases. Phase 1 (Ramp 1) starts at 0.6 mg per dose; the final phase (Maintenance) reaches 3 mg. Individual response and provider guidance can extend or shorten the timeline.
Liraglutide — Daily Ramp defaults to a 18 mg vial reconstituted with 3 ml of bacteriostatic water — a concentration of 6.00 mg/ml. The reconstitution calculator on this site lets you adjust to whatever vial size you actually have.
Liraglutide is FDA-approved, and protocols similar to Liraglutide — Daily Ramp appear in the prescribing information. The specific schedule shown here is a starting template — your provider may adjust it based on individual response and tolerability.
Most GLP-1 protocols share a common side-effect pattern documented on the parent peptide page. Track them in a timeline view (the iOS app does this automatically) so you can see whether symptoms are settling at the current dose or worsening — that is the signal that determines whether to advance the next phase or hold.
No. Liraglutide — Daily Ramp is a reference template summarizing patterns from authoritative sources. It is not a personalized treatment plan. Talk to a licensed healthcare provider before starting, modifying, or stopping any peptide protocol.
More GLP-1 protocols
Semaglutide — Standard Titration
PopularThe classic 16-week ramp: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly
View protocolSemaglutide — Gentle Start
Slower ramp for sensitive users — 8 weeks at each dose
View protocolTirzepatide — Standard Titration
Popular20-week ramp: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg weekly
View protocolTirzepatide — Aggressive
Faster dose escalation for experienced users — 12 weeks to 15mg
View protocolRetatrutide — Escalating
Research-backed ramp: 2 → 4 → 8 → 12 mg weekly over 16 weeks
View protocol
Run this protocol on autopilot
The iOS app advances this ramp week by week, fires reminders, and keeps a doctor-ready record.
Download on theApp Store